FDA Approves First Gene Therapy, Elevidys, to Treat Duchenne Muscular Dystrophy

FRIDAY, June 23, 2023 -- The U.S. Food and Drug Administration on Thursday approved the drug Elevidys, the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD).
The groundbreaking treatment will not be cheap:...